| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | AQUA | Common Stock | Disposed to Issuer | -16.2K | -100% | 0 | May 24, 2023 | Direct | F1 | ||
| transaction | AQUA | Common Stock | Disposed to Issuer | -49.7K | -100% | 0 | May 24, 2023 | By Trust | F2, F3 | ||
| transaction | AQUA | Common Stock | Disposed to Issuer | -40K | -100% | 0 | May 24, 2023 | By FIC | F2, F4 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | AQUA | Stock Option (Right to Buy) | Disposed to Issuer | -44.9K | -100% | 0 | May 24, 2023 | Common Stock | 44.9K | $4.64 | Direct | F5, F6 |
Martin Lamb is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.
| Id | Content |
|---|---|
| F1 | Disposed of pursuant to the merger agreement among Xylem Inc., Fore Merger Sub, Inc. and the issuer, dated as of Jan. 22, 2023. Upon effectiveness of the merger on May 24, 2023, (i) each issued and outstanding share of issuer common stock was exchanged for 0.48 Xylem common shares, with cash paid in lieu of fractional shares, and (ii) unvested restricted stock units ("RSUs") were converted into RSUs for Xylem common shares, by multiplying the number of shares of issuer common stock underlying the award and 0.48, rounded down to the nearest whole share. |
| F2 | Disposed of upon effectiveness of the merger, in which each issued and outstanding share of issuer common stock was exchanged for 0.48 Xylem common shares, with cash paid in lieu of fractional shares. |
| F3 | Shares held by a Bare trust, for the benefit of the reporting person's immediate family members and for which the reporting person retains investment control. |
| F4 | Shares held by an FIC, for which the reporting person retains investment control. The reporting person disclaims beneficial ownership with respect to these securities except to the extent of his pecuniary interest therein. |
| F5 | This option is fully vested. Pursuant to the merger agreement, each unexercised option to purchase issuer common stock was assumed by Xylem and converted into an option to purchase Xylem common shares. The number of Xylem common shares subject to the Xylem option is equal to the number of shares of issuer common stock underlying the options multiplied by 0.48, rounded down to the nearest whole share. |
| F6 | Pursuant to the merger agreement, the Xylem option exercise price is equal to the issuer option exercise price divided by 0.48, rounded up to the nearest whole cent. |